Skip to main content

Novel Molecular Targets for the Prevention of Fetal Alcohol Syndrome

Buy Article:

$68.00 + tax (Refund Policy)

Alcohol abuse produces damaging effects on the CNS that leads to several types of disorders. When consumed during pregnancy, alcohol may cause craniofacial malformations, growth retardation and brain damage in offspring. These symptoms are grouped by the term fetal alcohol syndrome (FAS). FAS is the most common cause of non-genetic mental retardation in the western world. Substantial efforts to elucidate the molecular basis of these impairments are currently in progress. Whereas FAS is totally preventable by avoiding alcohol intake during pregnancy, efficient therapies to prevent or mitigate the effects of prenatal alcohol exposure are still not available but many pharmacological treatments have been developed to avoid alcohol intake and dependence in adults. The present article reviews the most relevant mechanisms of alcohol injury in developing brain and the strategies and patents that are currently available and in progress to prevent therapy for FAS.





Keywords: Fetal alcohol syndrome; antioxidants; central nervous system; ethanol; fetal alcohol spectrum disorders; glia; lysophosphatidic acid; neuron; patents; retinol

Document Type: Research Article

Affiliations: Gustavo Egea, Departament de Biologia Cellular i Anatomia patològica, Facultat de Medicina, Universitat de Barcelona, c/ Casanova 143, 08036 Barcelona, Spain.

Publication date: 01 January 2007

More about this publication?
  • Recent Patents on CNS Drug Discovery publishes review articles on recent patents in the field of CNS drug discovery e.g. novel bioactive compounds, analogs & targets. A selection of important and recent patents on CNS drug discovery is also included in the journal. The journal is essential reading for all researchers involved in CNS drug design and discovery.
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content